|Bid||59.50 x 1200|
|Ask||59.53 x 1800|
|Day's Range||59.24 - 60.99|
|52 Week Range||20.84 - 75.80|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
It's been a mediocre week for Silk Road Medical, Inc (NASDAQ:SILK) shareholders, with the stock dropping 11% to...
Joining me are Erica Rogers, Chief Executive Officer; and Lucas Buchanan, Chief Financial Officer and Chief Operating Officer. Earlier today, Silk Road Medical released financial results for the quarter ended September 30, 2020. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
Silk Road Medical (SILK) delivered earnings and revenue surprises of -10.71% and 6.93%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?